CHI3L1 and Cirrhosis: Throughout the long‐term follow‐up, patients with cirrhosis consistently presented higher levels of APRI, FIB‐4, and serum CHI3L1 compared to those without cirrhosis (p < 0.05, Figure 5A,D,G).